查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945364

2026年全球體外診斷市場報告

In Vitro Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷市場發展迅速，預計將從2025年的1,365.5億美元成長到2026年的1,524.2億美元，複合年成長率達11.6%。過去幾年的成長可歸因於多種因素，例如診斷檢測量的增加、傳染病篩檢的加強、慢性病負擔的加重、檢查室基礎設施的改善以及醫療保健服務的可及性提高。

預計未來幾年體外診斷市場將快速成長，到2030年市場規模將達到2,411.4億美元，複合年成長率（CAGR）為12.2%。預測期內的成長要素包括：分散式診斷的日益普及、分子檢測技術投資的增加、個人化醫療診斷的擴展、對快速準確檢測需求的成長以及人工智慧驅動診斷技術的日益融合。預測期內的主要趨勢包括：照護現場診斷設備的日益普及、對分子和免疫檢測檢測需求的成長、自動化檢測系統的日益普及、多重診斷平台的擴展以及對快速檢測的日益重視。

癌症發生率的上升預計將推動體外診斷（IVD）市場的成長。癌症涵蓋100多種疾病，可發生於身體的各部位。癌症發生率的上升主要歸因於生活方式因素，例如吸煙增加、飲食不健康、缺乏運動和環境污染，這些因素都會增加人群的整體癌症風險。體外診斷（IVD）是一類檢測和醫療設備，用於分析從人體採集的檢體，為癌症篩檢、診斷和治療提供重要資訊。例如，根據美國國家生物技術資訊中心（NCBI）—一個政府間組織—於2023年1月發布的數據，預計2023年美國新增癌症病例和癌症相關死亡人數將分別達到1,958,310例和609,820例。因此，癌症發生率的上升預計將推動對體外診斷的需求。

體外診斷 (IVD) 市場的主要企業正在整合先進技術，例如 UIMG 成像技術和2D解碼晶片，以提高診斷的準確性和效率，改進數據分析，最佳化工作流程，並最終改善患者的治療效果。 UIMG 成像技術是一種先進的成像技術，能夠擷取和分析高解析度影像，從而提高生物樣本的可視化和解讀效果。例如，2023 年 11 月，總部位於歐洲、中東和非洲地區的荷蘭科技公司 Neuland 發布了全新的 IVD 產品線。該產品線包含五款緊湊耐用的條碼掃描器，旨在最佳化自動化診斷流程，滿足日益成長的高效醫療解決方案需求，並提高診斷的速度和準確性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 照護現場診斷設備的應用日益普及
    • 對分子和免疫檢測檢測的需求不斷成長
    • 擴大自動化檢測系統的應用
    • 擴展多診斷平台
    • 人們對快速檢測的興趣日益濃厚

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 診斷檢查室
  • 研究所
  • 公共衛生研究所
  • 生技公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球體外診斷市場規模、對比及成長率分析
  • 全球體外診斷市場表現：規模與成長，2020-2025年
  • 全球體外診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過診斷
  • 照護現場診斷設備、免疫化學診斷設備、臨床化學診斷設備、分子診斷設備、微生物診斷設備、止血診斷設備、血液診斷設備、免疫血液診斷設備
  • 按支出類型分類
  • 公營和私營機構
  • 最終用戶
  • 醫院和診所、診斷檢查室及其他終端用戶
  • 按類型細分：照護現場診斷儀器和設備
  • 血糖監測、懷孕及不孕症檢測、傳染病檢查、心臟標記檢測、血液凝固檢驗
  • 按類型細分：免疫化學診斷儀器和設備
  • 酵素免疫分析法（ELISA）、免疫檢測（RIA）、西方墨點法、螢光、化學冷光免疫檢測（CLIA）
  • 按類型細分：臨床化學診斷儀器及設備
  • 血糖檢測、膽固醇檢測、肝功能檢查、腎功能檢查、電解質檢查
  • 按類型細分：分子診斷儀器和設備
  • 聚合酵素鏈鎖反應（PCR）設備、次世代定序（NGS）設備、微陣列設備、螢光原位雜合反應（FISH）設備
  • 按類型細分：微生物診斷儀器及設備
  • 微生物培養系統、自動鑑定系統、抗菌藥物敏感性測試系統、血液培養系統
  • 按類型細分：止血診斷設備和裝置
  • 凝血分析儀、血栓彈力圖系統、血小板功能分析儀、凝血因子分析儀
  • 按類型細分：血液學診斷儀器及設備
  • 血液分析儀、血紅素測量系統、全血球計數儀（CBC）、血球計數器
  • 按類型細分：免疫血液學診斷儀器及設備
  • 血型鑑定系統、交叉配對試驗系統、抗體篩檢系統、血庫分析儀

第10章 區域與國家分析

  • 全球體外診斷市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球體外診斷市場：依國家分類、績效及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 孟加拉國市場

第19章 泰國市場

第20章 越南市場

第21章 馬來西亞市場

第22章 新加坡市場

第23章：菲律賓市場

第24章 香港市場

第25章：紐西蘭市場

第26章 台灣市場

第27章 東南亞市場

第28章 西歐市場

第29章英國市場

第30章：德國市場

第31章：法國市場

第32章：義大利市場

第33章：西班牙市場

第34章：奧地利市場

第35章：比利時市場

第36章：丹麥市場

第37章 芬蘭市場

第38章：愛爾蘭市場

第39章：荷蘭市場

第40章：挪威市場

第41章：葡萄牙市場

第42章：瑞典市場

第42章 瑞士市場

第43章 東歐市場

第44章：俄羅斯市場

第45章：捷克市場

第46章：波蘭市場

第47章：羅馬尼亞市場

第48章：烏克蘭市場

第49章 北美市場

第50章：美國市場

第51章 加拿大市場

第52章：墨西哥市場

第53章 南美洲市場

第54章：巴西市場

第55章 智利市場

第56章：阿根廷市場

第57章：哥倫比亞市場

第58章 秘魯市場

第59章 中東市場

第60章：沙烏地阿拉伯市場

第61章：以色列市場

第62章 伊朗市場

第63章 土耳其市場

第64章：阿拉伯聯合大公國市場

第65章：非洲市場

第66章 埃及市場

第67章：奈及利亞市場

第68章 南非市場

第69章 市場監理與投資環境

第70章：競爭格局與公司概況

  • 體外診斷市場：競爭格局及市場佔有率（2024年）
  • 體外診斷市場：公司估值矩陣
  • 體外診斷市場：公司概況
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Abbott Laboratories Inc.
    • Thermo Fisher Scientific Inc.

第71章：其他領先和創新企業

  • Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company（BD）, Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc.

第72章：全球市場競爭基準分析與儀錶板

第73章：重大併購

第74章：高潛力市場國家、細分市場與策略

  • 2030年體外診斷市場：提供新機會的國家
  • 2030年體外診斷市場：充滿新機會的細分市場
  • 2030年體外診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第75章附錄

簡介目錄
Product Code: ME2MIVDI03_G26Q1

In vitro diagnostics (IVD) are tests performed on biological samples, such as blood, tissue, or urine, collected from the human body to identify diseases, conditions, or infections. Conducted outside the body in controlled environments like laboratories, these tests utilize specialized equipment and reagents. IVDs play a vital role in diagnosing various health conditions, guiding treatment decisions, and monitoring patient health over time.

The principal categories of in-vitro diagnostics equipment encompass point-of-care diagnostics devices and equipment, immunochemistry diagnostic devices and equipment, clinical chemistry diagnostics devices and equipment, molecular diagnostics devices and equipment, microbiology diagnostic devices and equipment, hemostasis diagnostic devices and equipment, hematology diagnostic devices and equipment, and immunohematology diagnostic devices and equipment. Hematology instruments, for instance, are machines designed to analyze blood samples, perform blood counts, detect proteins or enzymes, and aid in the diagnosis of diseases or genetic defects. These devices and equipment are used in both public and private settings and involve instruments/equipment as well as disposables. The end-users for these tools include hospitals and clinics, diagnostic laboratories, and other relevant institutions.

Tariffs are influencing the in vitro diagnostics market by increasing costs of imported analyzers, reagents, microfluidic components, and optical systems used across diagnostic platforms. North America and Europe are most affected due to reliance on globally sourced diagnostic equipment, while Asia-Pacific faces higher costs for reagent imports and exports. These tariffs are raising testing costs and delaying laboratory upgrades. However, they are also encouraging domestic manufacturing, regional reagent production, and strengthened local diagnostic supply chains.

The in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics market statistics, including in vitro diagnostics industry global market size, regional shares, competitors with a in vitro diagnostics market share, detailed in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the in vitro diagnostics industry. This in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vitro diagnostics market size has grown rapidly in recent years. It will grow from $136.55 billion in 2025 to $152.42 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to expansion of diagnostic testing volumes, growth in infectious disease screening, rising burden of chronic diseases, improvements in laboratory infrastructure, increasing healthcare access.

The in vitro diagnostics market size is expected to see rapid growth in the next few years. It will grow to $241.14 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising investments in molecular testing technologies, expansion of personalized medicine diagnostics, growing demand for rapid and accurate testing, increasing integration of ai-driven diagnostics. Major trends in the forecast period include increasing adoption of point-of-care diagnostic devices, rising demand for molecular and immunoassay testing, growing use of automated laboratory systems, expansion of multiplex diagnostic platforms, enhanced focus on rapid testing.

The rising prevalence of cancer is expected to drive the growth of the in vitro diagnostics (IVD) market. Cancer encompasses over 100 different diseases that can develop in various parts of the body. The increasing incidence of cancer is largely attributed to lifestyle factors such as increased tobacco use, poor diet, physical inactivity, and environmental pollution, all of which elevate the risk of cancer across populations. In vitro diagnostics (IVDs) are a category of tests or medical devices that analyze samples taken from the human body, providing essential information for the screening, diagnosis, and treatment of cancer. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported that there were 1,958,310 new cancer cases and an estimated 609,820 cancer deaths in the United States in 2023. As a result, the growing prevalence of cancer is expected to propel the demand for in vitro diagnostics.

Major players in the in vitro diagnostics (IVD) market are incorporating advanced technologies, such as UIMG image technology and 2D decoder chips, to enhance diagnostic accuracy and efficiency, improve data analysis, optimize workflows, and ultimately deliver better patient outcomes. UIMG image technology is an advanced imaging technique used in diagnostics to capture and analyze high-resolution images, enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, a Netherlands-based technology company in the EMEA region, launched a new IVD product line. This product line includes five barcode scanners that are compact, durable, and designed to optimize automated diagnostic processes, aiming to boost diagnostic speed and accuracy in response to the growing demand for efficient healthcare solutions.

In June 2025, bioMerieux, a France-based provider of in vitro diagnostics solutions, acquired Day Zero Diagnostics for approximately $25 million. This acquisition strengthens bioMerieux's next-generation sequencing (NGS) capabilities and enhances its rapid diagnostics portfolio, allowing the company to better address antibiotic-resistant infections and improve the management of life-threatening infectious diseases. Day Zero Diagnostics, a US-based company, specializes in genome sequencing and machine learning technologies that enable the rapid identification of bacterial pathogens and their antibiotic resistance profiles directly from whole blood samples

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The in-vitro diagnostics devices and equipment market consist of sales of kits, reagents, piece of software, system, and instrument. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in vitro diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment; Immunochemistry Diagnostic Devices And Equipment; Clinical Chemistry Diagnostics Devices And Equipment; Molecular Diagnostics Devices And Equipment; Microbiology Diagnostic Devices And Equipment; Hemostasis Diagnostic Devices And Equipment; Hematology Diagnostic Devices And Equipment; Immunohematology Diagnostic Devices And Equipment
  • 2) By Type of Expenditure: Public; Private
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring; Pregnancy And Fertility Testing; Infectious Disease Testing; Cardiac Markers Testing; Coagulation Testing
  • 2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA); Western Blot; Immunofluorescence Assay; Chemiluminescence Immunoassay (CLIA)
  • 3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing; Cholesterol Testing; Liver Function Testing; Kidney Function Testing; Electrolyte Testing
  • 4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; FISH (Fluorescence In Situ Hybridization) Devices
  • 5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems; Automated Identification Systems; Antimicrobial Susceptibility Testing Systems; Blood Culture Systems
  • 6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers; Thromboelastography Systems; Platelet Function Analyzers; Clotting Factor Analyzers
  • 7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers; Hemoglobin Testing Systems; Complete Blood Count (CBC) Devices; Blood Cell Counters
  • 8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems; Crossmatching Systems; Antibody Screening Systems; Blood Bank Analyzers
  • Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Danaher Corporation; Abbott Laboratories Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Alere Inc.; Arkray Inc.; Becton Dickinson and Company (BD); Bio-Rad Laboratories Inc.; bioMerieux SA; Grifols SA; Hologic Inc.; Werfen SA; Laboratory Corporation; Luminex Corporation; Ortho Clinical Diagnostics; PerkinElmer Inc.; Qiagen NV; Quest Diagnostics Inc.; QuidelOrtho Corporation; Sysmex Corporation; Illumina Inc.; Menarini Silicon Biosystems SPA; SpeeDx Pty. Ltd.; GENSPEED Biotech GmbH; Accelerate Diagnostics Inc.; Merck KGaA; Caris Life Sciences Inc.; Bio-Techne Corporation; Myriad Genetics Inc.; Genomic Health Inc.; Exact Sciences Crop.; Natera Inc.; Invitae Crop.; Veracyte Inc.
  • Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In Vitro Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In Vitro Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In Vitro Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In Vitro Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Point-Of-Care Diagnostic Devices
    • 4.2.2 Rising Demand For Molecular And Immunoassay Testing
    • 4.2.3 Growing Use Of Automated Laboratory Systems
    • 4.2.4 Expansion Of Multiplex Diagnostic Platforms
    • 4.2.5 Enhanced Focus On Rapid Testing

5. In Vitro Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Diagnostic Laboratories
  • 5.3 Research Institutes
  • 5.4 Public Health Laboratories
  • 5.5 Biotechnology Companies

6. In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In Vitro Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In Vitro Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In Vitro Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In Vitro Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In Vitro Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In Vitro Diagnostics Market Segmentation

  • 9.1. Global In Vitro Diagnostics Market, Segmentation By Diagnostic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
  • 9.2. Global In Vitro Diagnostics Market, Segmentation By Type of Expenditure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Public, Private
  • 9.3. Global In Vitro Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Diagnostic Laboratories, Other End Users
  • 9.4. Global In Vitro Diagnostics Market, Sub-Segmentation Of Point-Of-Care Diagnostics Devices And Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
  • 9.5. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunochemistry Diagnostic Devices And Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
  • 9.6. Global In Vitro Diagnostics Market, Sub-Segmentation Of Clinical Chemistry Diagnostic Devices And Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
  • 9.7. Global In Vitro Diagnostics Market, Sub-Segmentation Of Molecular Diagnostics Devices And Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
  • 9.8. Global In Vitro Diagnostics Market, Sub-Segmentation Of Microbiology Diagnostic Devices And Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
  • 9.9. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hemostasis Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
  • 9.10. Global In Vitro Diagnostics Market, Sub-Segmentation Of Hematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
  • 9.11. Global In Vitro Diagnostics Market, Sub-Segmentation Of Immunohematology Diagnostic Devices and Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

10. In Vitro Diagnostics Market Regional And Country Analysis

  • 10.1. Global In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In Vitro Diagnostics Market

  • 11.1. Asia-Pacific In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In Vitro Diagnostics Market

  • 12.1. China In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In Vitro Diagnostics Market

  • 13.1. India In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In Vitro Diagnostics Market

  • 14.1. Japan In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In Vitro Diagnostics Market

  • 15.1. Australia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In Vitro Diagnostics Market

  • 16.1. Indonesia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In Vitro Diagnostics Market

  • 17.1. South Korea In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Bangladesh In Vitro Diagnostics Market

  • 18.1. Bangladesh In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Thailand In Vitro Diagnostics Market

  • 19.1. Thailand In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Vietnam In Vitro Diagnostics Market

  • 20.1. Vietnam In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Malaysia In Vitro Diagnostics Market

  • 21.1. Malaysia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Singapore In Vitro Diagnostics Market

  • 22.1. Singapore In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Philippines In Vitro Diagnostics Market

  • 23.1. Philippines In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Hong Kong In Vitro Diagnostics Market

  • 24.1. Hong Kong In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. New Zealand In Vitro Diagnostics Market

  • 25.1. New Zealand In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Taiwan In Vitro Diagnostics Market

  • 26.1. Taiwan In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Taiwan In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. South East Asia In Vitro Diagnostics Market

  • 27.1. South East Asia In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. South East Asia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Western Europe In Vitro Diagnostics Market

  • 28.1. Western Europe In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. Western Europe In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. UK In Vitro Diagnostics Market

  • 29.1. UK In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Germany In Vitro Diagnostics Market

  • 30.1. Germany In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. France In Vitro Diagnostics Market

  • 31.1. France In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Italy In Vitro Diagnostics Market

  • 32.1. Italy In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Spain In Vitro Diagnostics Market

  • 33.1. Spain In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Austria In Vitro Diagnostics Market

  • 34.1. Austria In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Belgium In Vitro Diagnostics Market

  • 35.1. Belgium In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Denmark In Vitro Diagnostics Market

  • 36.1. Denmark In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

37. Finland In Vitro Diagnostics Market

  • 37.1. Finland In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

38. Ireland In Vitro Diagnostics Market

  • 38.1. Ireland In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

39. Netherlands In Vitro Diagnostics Market

  • 39.1. Netherlands In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

40. Norway In Vitro Diagnostics Market

  • 40.1. Norway In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

41. Portugal In Vitro Diagnostics Market

  • 41.1. Portugal In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Sweden In Vitro Diagnostics Market

  • 42.1. Sweden In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

42. Switzerland In Vitro Diagnostics Market

  • 42.1. Switzerland In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

43. Eastern Europe In Vitro Diagnostics Market

  • 43.1. Eastern Europe In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 43.2. Eastern Europe In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

44. Russia In Vitro Diagnostics Market

  • 44.1. Russia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

45. Czech Republic In Vitro Diagnostics Market

  • 45.1. Czech Republic In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

46. Poland In Vitro Diagnostics Market

  • 46.1. Poland In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

47. Romania In Vitro Diagnostics Market

  • 47.1. Romania In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

48. Ukraine In Vitro Diagnostics Market

  • 48.1. Ukraine In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

49. North America In Vitro Diagnostics Market

  • 49.1. North America In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 49.2. North America In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

50. USA In Vitro Diagnostics Market

  • 50.1. USA In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 50.2. USA In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

51. Canada In Vitro Diagnostics Market

  • 51.1. Canada In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 51.2. Canada In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

52. Mexico In Vitro Diagnostics Market

  • 52.1. Mexico In Vitro Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 52.2. Mexico In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

53. South America In Vitro Diagnostics Market

  • 53.1. South America In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 53.2. South America In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

54. Brazil In Vitro Diagnostics Market

  • 54.1. Brazil In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

55. Chile In Vitro Diagnostics Market

  • 55.1. Chile In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

56. Argentina In Vitro Diagnostics Market

  • 56.1. Argentina In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

57. Colombia In Vitro Diagnostics Market

  • 57.1. Colombia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

58. Peru In Vitro Diagnostics Market

  • 58.1. Peru In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

59. Middle East In Vitro Diagnostics Market

  • 59.1. Middle East In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 59.2. Middle East In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

60. Saudi Arabia In Vitro Diagnostics Market

  • 60.1. Saudi Arabia In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

61. Israel In Vitro Diagnostics Market

  • 61.1. Israel In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

62. Iran In Vitro Diagnostics Market

  • 62.1. Iran In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

63. Turkey In Vitro Diagnostics Market

  • 63.1. Turkey In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

64. United Arab Emirates In Vitro Diagnostics Market

  • 64.1. United Arab Emirates In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

65. Africa In Vitro Diagnostics Market

  • 65.1. Africa In Vitro Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 65.2. Africa In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

66. Egypt In Vitro Diagnostics Market

  • 66.1. Egypt In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

67. Nigeria In Vitro Diagnostics Market

  • 67.1. Nigeria In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

68. South Africa In Vitro Diagnostics Market

  • 68.1. South Africa In Vitro Diagnostics Market, Segmentation By Diagnostic, Segmentation By Type of Expenditure, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

69. In Vitro Diagnostics Market Regulatory and Investment Landscape

70. In Vitro Diagnostics Market Competitive Landscape And Company Profiles

  • 70.1. In Vitro Diagnostics Market Competitive Landscape And Market Share 2024
    • 70.1.1. Top 10 Companies (Ranked by revenue/share)
  • 70.2. In Vitro Diagnostics Market - Company Scoring Matrix
    • 70.2.1. Market Revenues
    • 70.2.2. Product Innovation Score
    • 70.2.3. Brand Recognition
  • 70.3. In Vitro Diagnostics Market Company Profiles
    • 70.3.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 70.3.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

71. In Vitro Diagnostics Market Other Major And Innovative Companies

  • Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMerieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc.

72. Global In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

73. Key Mergers And Acquisitions In The In Vitro Diagnostics Market

74. In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

  • 74.1 In Vitro Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 74.2 In Vitro Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 74.3 In Vitro Diagnostics Market In 2030 - Growth Strategies
    • 74.3.1 Market Trend Based Strategies
    • 74.3.2 Competitor Strategies

75. Appendix

  • 75.1. Abbreviations
  • 75.2. Currencies
  • 75.3. Historic And Forecast Inflation Rates
  • 75.4. Research Inquiries
  • 75.5. The Business Research Company
  • 75.6. Copyright And Disclaimer